Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
74.04
-1.12 (-1.49%)
At close: Mar 6, 2026, 4:00 PM EST
73.63
-0.42 (-0.56%)
After-hours: Mar 6, 2026, 6:40 PM EST
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,402 employees as of December 31, 2025. The number of employees increased by 333 or 31.15% compared to the previous year.
Employees
1,402
Change (1Y)
333
Growth (1Y)
31.15%
Revenue / Employee
$673,118
Profits / Employee
-$272,031
Market Cap
12.23B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Genmab | 2,973 |
| Jazz Pharmaceuticals | 2,890 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| BridgeBio Pharma | 839 |
| ImmunityBio | 691 |
IONS News
- 3 days ago - Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences - GlobeNewsWire
- 6 days ago - Ionis Pharmaceuticals, Inc. (IONS) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 9 days ago - Ionis to present new data supporting DAWNZERA™ (donidalorsen) in hereditary angioedema at 2026 AAAAI Annual Meeting - Business Wire
- 9 days ago - Ionis Pharmaceuticals: Digesting Recent Events - Seeking Alpha
- 10 days ago - Ionis Pharmaceuticals, Inc. (IONS) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript - Seeking Alpha
- 10 days ago - Olezarsen sNDA accepted by the FDA for Priority Review for the treatment of severe hypertriglyceridemia (sHTG) - Business Wire
- 11 days ago - Ionis Pharmaceuticals, Inc. (IONS) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Ionis Guides Below 2026 Sales Views Despite Strong Growth From Lead Drug - Benzinga